1. Home
  2. AYTU vs SQFT Comparison

AYTU vs SQFT Comparison

Compare AYTU & SQFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AYTU
  • SQFT
  • Stock Information
  • Founded
  • AYTU N/A
  • SQFT 1999
  • Country
  • AYTU United States
  • SQFT United States
  • Employees
  • AYTU N/A
  • SQFT N/A
  • Industry
  • AYTU Biotechnology: Pharmaceutical Preparations
  • SQFT Real Estate Investment Trusts
  • Sector
  • AYTU Health Care
  • SQFT Real Estate
  • Exchange
  • AYTU Nasdaq
  • SQFT Nasdaq
  • Market Cap
  • AYTU 8.3M
  • SQFT 8.1M
  • IPO Year
  • AYTU N/A
  • SQFT 2020
  • Fundamental
  • Price
  • AYTU $1.10
  • SQFT $0.63
  • Analyst Decision
  • AYTU
  • SQFT
  • Analyst Count
  • AYTU 0
  • SQFT 0
  • Target Price
  • AYTU N/A
  • SQFT N/A
  • AVG Volume (30 Days)
  • AYTU 30.8K
  • SQFT 39.2K
  • Earning Date
  • AYTU 05-14-2025
  • SQFT 05-13-2025
  • Dividend Yield
  • AYTU N/A
  • SQFT N/A
  • EPS Growth
  • AYTU N/A
  • SQFT N/A
  • EPS
  • AYTU N/A
  • SQFT N/A
  • Revenue
  • AYTU $77,232,000.00
  • SQFT $18,925,275.00
  • Revenue This Year
  • AYTU N/A
  • SQFT $23.63
  • Revenue Next Year
  • AYTU $8.14
  • SQFT N/A
  • P/E Ratio
  • AYTU N/A
  • SQFT N/A
  • Revenue Growth
  • AYTU N/A
  • SQFT 7.31
  • 52 Week Low
  • AYTU $0.95
  • SQFT $0.47
  • 52 Week High
  • AYTU $3.45
  • SQFT $1.03
  • Technical
  • Relative Strength Index (RSI)
  • AYTU 42.38
  • SQFT 56.48
  • Support Level
  • AYTU $0.99
  • SQFT $0.62
  • Resistance Level
  • AYTU $1.10
  • SQFT $0.66
  • Average True Range (ATR)
  • AYTU 0.08
  • SQFT 0.03
  • MACD
  • AYTU 0.01
  • SQFT 0.01
  • Stochastic Oscillator
  • AYTU 50.00
  • SQFT 84.17

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.

About SQFT Presidio Property Trust Inc.

Presidio Property Trust Inc is an internally managed, diversified REIT with holdings in model home properties which are triple-net leased to homebuilders, office, industrial, and retail properties. Presidio's model homes are leased to homebuilders located in Arizona, Illinois, Texas, Wisconsin, and Florida. The office, industrial and retail properties are located primarily in Colorado, with properties also located in Maryland, North Dakota, Texas, and Southern California.

Share on Social Networks: